GlassScriptPhysician profile
Justin B King
NPI 1629262258
$12,464.04
in general payments reported to CMS, 2019-2025
13 companies · $5,883 in 2025
The $5,883 reported for 2025 was more than what 92% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,380 · 2020: $920 · 2021: $56.02 · 2022: $18.46 · 2023: $1,063 · 2024: $144 · 2025: $5,883.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,500 · Travel and Lodging: $2,477 · Food and Beverage: $1,138 · Consulting Fee: $975.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,500.00 |
| Travel and Lodging | $2,477.05 |
| Food and Beverage | $1,137.88 |
| Consulting Fee | $975.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,393.71 | 2024-2025 | |
| Heron Therapeutics, INC. | $4,250.00 | 2019-2020 | |
| Medtronic, INC. | $999.07 | 2023 | Sonicision |
| Covidien LP | $980.00 | 2019 | |
| Davol INC. | $273.95 | 2025 | Phasix Mesh |
| Ethicon US, LLC | $175.88 | 2021-2025 | Harmonic, Dermabond Prineo, Dermabond |
| Procept Biorobotics Corporation | $112.61 | 2024-2025 | Aquabeam System |
| Viiv Healthcare Company | $86.78 | 2025 | |
| Kerecis Limited | $83.67 | 2023-2025 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Baxter Healthcare | $57.35 | 2020 | |
| Philips North America LLC | $20.28 | 2023 | |
| Stryker Corporation | $18.46 | 2022 | |
| Avanos Medical | $12.28 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.